PDCD1 and head and neck squamous cell carcinoma: In an experiment involving neck squamous cell carcinoma (HNSCC), the pretreatment of HNSCC cells with melatonin did not further enhance T cell activity when the PD-1/PD-L1 signaling was blocked by anti-PD-L1 antibodies.